These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1732538)

  • 21. N6-(arylalkyl)adenosines. Identification of N6-(9-fluorenylmethyl)adenosine as a highly potent agonist for the adenosine A2 receptor.
    Trivedi BK; Bristol JA; Bruns RF; Haleen SJ; Steffen RP
    J Med Chem; 1988 Jan; 31(1):271-3. PubMed ID: 3336027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N6-substituted adenosine receptor agonists: potential antihypertensive agents.
    Trivedi BK; Blankley CJ; Bristol JA; Hamilton HW; Patt WC; Kramer WJ; Johnson SA; Bruns RF; Cohen DM; Ryan MJ
    J Med Chem; 1991 Mar; 34(3):1043-9. PubMed ID: 2002448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular simulation of 8-styrylxanthines.
    Mager PP; Reinhardt R; Richter M; Walther H; Rockel B
    Drug Des Discov; 1995 Nov; 13(2):89-107. PubMed ID: 8872454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N6-[2-(3,5-dimethoxyphenyl)-2-(2-methylphenyl)ethyl]adenosine and its uronamide derivatives. Novel adenosine agonists with both high affinity and high selectivity for the adenosine A2 receptor.
    Bridges AJ; Bruns RF; Ortwine DF; Priebe SR; Szotek DL; Trivedi BK
    J Med Chem; 1988 Jul; 31(7):1282-5. PubMed ID: 3385722
    [No Abstract]   [Full Text] [Related]  

  • 25. Affinity of central adenosine A1 receptors is decreased in spontaneously hypertensive rats.
    Matias A; Zimmer FJ; Lorenzen A; Keil R; Schwabe U
    Eur J Pharmacol; 1993 Feb; 244(3):223-30. PubMed ID: 8458399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of amiloride and its analogues with adenosine A1 receptors in calf brain.
    Garritsen A; Ijzerman AP; Beukers MW; Cragoe EJ; Soudijn W
    Biochem Pharmacol; 1990 Aug; 40(4):827-34. PubMed ID: 2143655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N6-bicycloalkyladenosines with unusually high potency and selectivity for the adenosine A1 receptor.
    Trivedi BK; Bridges AJ; Patt WC; Priebe SR; Bruns RF
    J Med Chem; 1989 Jan; 32(1):8-11. PubMed ID: 2909748
    [No Abstract]   [Full Text] [Related]  

  • 28. Adenosine derivatives with N6-alkyl, -alkylamine or -alkyladenosine substituents as probes for the A1-receptor.
    van Galen PJ; Ijzerman AP; Soudijn W
    FEBS Lett; 1987 Oct; 223(1):197-201. PubMed ID: 2959564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 1,3,8-trisubstituted xanthines. Effects of substitution pattern upon adenosine receptor A1/A2 affinity.
    Erickson RH; Hiner RN; Feeney SW; Blake PR; Rzeszotarski WJ; Hicks RP; Costello DG; Abreu ME
    J Med Chem; 1991 Apr; 34(4):1431-5. PubMed ID: 2016719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Density gradient profiles of A1 adenosine receptors labeled by agonist and antagonist radioligands before and after detergent solubilization.
    Leung E; Green RD
    Mol Pharmacol; 1989 Sep; 36(3):412-9. PubMed ID: 2506430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The adenosine A3 receptor and its ligands.
    van Muijlwijk-Koezen JE; Timmerman H; Ijzerman AP
    Prog Med Chem; 2001; 38():61-113. PubMed ID: 11774799
    [No Abstract]   [Full Text] [Related]  

  • 32. N6-phenyladenosines: pronounced effect of phenyl substituents on affinity for A2 adenosine receptors.
    Kwatra MM; Leung E; Hosey MM; Green RD
    J Med Chem; 1987 May; 30(5):954-6. PubMed ID: 3572985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of long-term theophylline treatment on adenosine A1-receptors in rat brain: autoradiographic evidence for increased receptor number and altered coupling to G-proteins.
    Fastbom J; Fredholm BB
    Brain Res; 1990 Jan; 507(2):195-9. PubMed ID: 2110844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allosteric enhancement of adenosine A1 receptor binding and function by 2-amino-3-benzoylthiophenes.
    Bruns RF; Fergus JH
    Mol Pharmacol; 1990 Dec; 38(6):939-49. PubMed ID: 2174510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Binding of adenosine analogs with A1-type purine receptors in the guinea pig ileum].
    Poltavchenko GM; Katkov VF; Pavlov VN; Travkin OV
    Biull Eksp Biol Med; 1990 Feb; 109(2):165-7. PubMed ID: 2337653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenosine receptors in brain membranes: binding of N6-cyclohexyl[3H]adenosine and 1,3-diethyl-8-[3H]phenylxanthine.
    Bruns RF; Daly JW; Snyder SH
    Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5547-51. PubMed ID: 6254090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenosine A1 antagonists. 3. Structure-activity relationships on amelioration against scopolamine- or N6-((R)-phenylisopropyl)adenosine-induced cognitive disturbance.
    Suzuki F; Shimada J; Shiozaki S; Ichikawa S; Ishii A; Nakamura J; Nonaka H; Kobayashi H; Fuse E
    J Med Chem; 1993 Aug; 36(17):2508-18. PubMed ID: 8355252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dog coronary artery adenosine receptor: structure of the N6-alkyl subregion.
    Kusachi S; Thompson RD; Bugni WJ; Yamada N; Olsson RA
    J Med Chem; 1985 Nov; 28(11):1636-43. PubMed ID: 2999397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N6-substituted N-alkyladenosine-5'-uronamides: bifunctional ligands having recognition groups for A1 and A2 adenosine receptors.
    Olsson RA; Kusachi S; Thompson RD; Ukena D; Padgett W; Daly JW
    J Med Chem; 1986 Sep; 29(9):1683-9. PubMed ID: 3018244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential binding properties of adenosine receptor agonists and antagonists in brain.
    Marangos PJ; Patel J; Martino AM; Dilli M; Boulenger JP
    J Neurochem; 1983 Aug; 41(2):367-74. PubMed ID: 6308158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.